More On

Pfizer settles Wyeth’s Protonix suit

Pharma giant will pay $55 million plus interest to end case

Pfizer Inc. said yesterday that it will shell out $55 million to bring to an end to litigation surrounding Protonix, an acid reflux drug that Wyeth, now owned by Pfizer, produced and marketed in the early 2000s.

The Department of Justice (DOJ) had accused Wyeth of marketing Protonix for unapproved uses and says the pharmaceutical company also made claims about the drug that had not been proved. The DOJ says the questionable marketing of Protonix occurred between February 2000 and June 2001. Pfizer purchased Wyeth for $68 billion in 2009.


Cathleen Flahardy

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.